![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | A61K 31/415 | |
C07D 231/38 | |||
A61P 29/00 |
(11) | Number of the document | 3484471 |
(13) | Kind of document | T |
(96) | European patent application number | 17742278.9 |
Date of filing the European patent application | 2017-07-13 | |
(97) | Date of publication of the European application | 2019-05-22 |
(45) | Date of publication and mention of the grant of the patent | 2021-05-05 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/GB2017/052056 |
Date | 2017-07-13 |
(87) | Number | WO 2018/011579 |
Date | 2018-01-18 |
(30) | Number | Date | Country code |
201612240 | 2016-07-14 | GB |
(72) |
SULEIMAN, Osama, GB
PEREZ, Lucia Romero, GB
HARLACHER, Cornelius Stephan, CH
JONES, Stewart, GB
|
(73) |
Mereo BioPharma 1 Limited,
1 Cavendish Place, London, Greater London W1G 0QF,
GB
|
(54) | METHOD FOR PRODUCING A POLYMORPHIC FORM OF 3-[5-AMINO-4-(3- CYANOBENZOYL)-PYRAZOL-1-YL]-N-CYCLOPROPYL-4-METHYLBENZAMIDE |
METHOD FOR PRODUCING A POLYMORPHIC FORM OF 3-[5-AMINO-4-(3- CYANOBENZOYL)-PYRAZOL-1-YL]-N-CYCLOPROPYL-4-METHYLBENZAMIDE |